𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CCL13 is a promising diagnostic marker for systemic sclerosis

✍ Scribed by K. Yanaba; A. Yoshizaki; E. Muroi; T. Hara; F. Ogawa; K. Shimizu; M. Hasegawa; M. Fujimoto; K. Takehara; S. Sato


Book ID
108670939
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
213 KB
Volume
162
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Is imatinib mesylate a promising drug in
✍ P. L. A. van Daele; W. A. Dik; H. B. Thio; P. Th. W. van Hal; J. A. M. van Laar; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract A patient with therapy‐resistant and progressive systemic sclerosis (SSc) with pulmonary involvement who was treated with imatinib mesylate is described herein. Prior to treatment, pulmonary fibroblasts obtained from the patient were cultured and incubated with imatinib mesylate. Preinc